행사
2026년 10월 20 – 22일
CGTP Europe 2026
Lisbon, Portugal

Presented by VIVEbiotech during the plenary session Innovative Strategies and Tools to Improve CGT Development and Manufacturing.
Leveraging Prior Knowledge to Accelerate Process Validation of a Lentiviral Vector for an Ultra-Orphan Autologous Cell-Based Gene Therapy | October 20 | 10:25 – 12:10 PM | VIVEbiotech speaker: Ana Valero, PhD
2026년 9월 29 – 01일
BIOSPAIN 2026
Bilbao, Spain
Bronze Sponsor
Participation in six roundtables:
- Making ATMPs sustainable in 2026: What gets funded, scaled, and acquired? | September 29, 4 – 4:45 PM | VIVEbiotech speaker: Jon Alberdi, CEO.
- From platform to patient: Scaling biotech and advanced therapies through integrated CDMO ecosystems | September 30, 11:30 AM–12:15 PM | VIVEbiotech speaker: Natalia Elizalde, PhD, Chief Business Development Officer.
- From science to thew market: The value of engineering across the biotech product lifecycle | September 30, 12:15 – 1 PM | VIVEbiotech speaker: Diego Bochoeyer, Chief Operating Officer.
- Gipuzkoa facing the future of biotechnology: challenges, opportunities and strategy | September 30, 2:30 – 3:15 PM | VIVEbiotech speaker: Jon Alberdi, CEO.
- Current innovation trends in therapeutic technologies and modalities: What is the potential of spain to ride these waves? | September 30, 3:15 – 4 PM | VIVEbiotech speaker: Gurutz Linazasoro, MD, Founder and Board Member.
- From lab coats to suits: essential roles in the biotech journey | October 1, 9:30 – 10:15 AM | VIVEbiotech speaker: Eva Peña, Attraction and Talent Management Head.
2026년 9월 07 – 09일
Advanced Therapies Europe 2026
Barcelona, Spain
Exhibitor, booth 56
Bronze Sponsor
Panel Leadership – From Early Development to Commercial Readiness: Real-World Lessons in Advancing Lentiviral-Based Therapies | September 09, 1:30 – 2:30 PM
Moderator: Patricio Massera, President & Board Member, VIVEbiotech.
Speakers:
- Natalia Elizalde, PhD. Chief Business Development Officer, VIVEbiotech.
- Miguel Forte, MD, PhD. CEO, Kiji Therapeutics.
- Willem-Jan Krebber, Mbiotech, MSc, Chief Development Officer, Genewity Holding B.V.
2026년 5월 11 – 15일
ASGCT Annual Meeting 2026
Boston, USA
Exhibitor, booth 1619
Company Presentation Shaping the Future of Lentiviral Vector Manufacturing: Versatile Platforms for Ex Vivo and In Vivo Applications, May 12, 4 PM
Sponsored Symposium by Sartorius A Collaborative Approach to Enabling Efficient LV Manufacturing for Ex Vivo and In Vivo Gene Therapies, May 12, 4:30 PM








































